The End­points Slack in­ter­view: Celli­no CEO Nabi­ha Sak­layen on cell ther­a­py's fu­ture, Elon Musk and time trav­el

Nabi­ha Sak­layen found­ed Celli­no Biotech just as she was fin­ish­ing her PhD in physics at Har­vard in 2017, while she was still in her 20s.

The start­up is try­ing to cre­ate au­to­mat­ed ways to pro­duce cell ther­a­pies and raised an $80 mil­lion Se­ries A round in 2022 to get to work. End­points News caught up with Sak­layen on how that ef­fort is go­ing, as well as her thoughts on Elon Musk, mis­sion con­trol at Celli­no, and even time trav­el.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.